// App-Quantinova.ai

: The Cell‐cycle Control Pathway Gwl/MASTL‐ENSA/ARPP19‐PP2A Is Present and Active in Human Platelets

Researchers

Presenter

  • E. Kumm

Principal Investigators

  • O. Pagel

  • S. Makhoul

  • R. Zahedi

  • A. Smolenski

  • S. Gambaryan

  • U. Walter

  • K. Jurk

Medical Centers

  • University Medical Center of the Johannes Gutenberg University, Center for Thrombosis and Hemostasis (CTH), Mainz, Germany

  • Leibniz‐Institut für Analytische Wisschenschaften, ISAS ‐ e.V., Dortmund, Germany

  • University Medical Center Mainz, Johannes Gutenberg‐University Mainz, Germany, Center for Thrombosis and Hemostasis, Mainz, Germany

  • Jewish General Hospital, Proteomics Centre, Lady Davis Institute, Montréal, Canada

  • UCD Conway Institute, UCD School of Medicine and Medical Science, University College Dublin, Dublin, Ireland

  • Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russian Federation

Locations

  • Germany

  • Canada

  • Ireland

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Protein Phosphatase 2 Phosphatase Activator

  • Cyclic AMP-dependent protein kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved